Glucose monitoring specialist Dexcom announced it received FDA clearance for its G7 15 Day continuous glucose monitoring (CGM) system for people 18 and older with type 1, type 2 and gestational diabetes.
G7 15 Day, scheduled to launch in the second half of this year, will have a 15.5-day wear time (including a 12-hour grace period) and last 15% longer than Dexcom G7, according to the company. ...
Cardiometabolic digital diagnostics company Nanowear announced a licensing and data partnership with glucose monitoring specialist Dexcom to integrate glucose data from the Dexcom G7 into its SimpleSense nanotechnology-enabled wearable.
Nanowear offers home-based, AI-enabled digital diagnostics for cardiometabolic health. The company's FDA-cleared SimpleSense wearable reads patient vitals, such...
Editor's note: This article has been updated with clarifying comments from Dexcom.
Glucose-monitoring specialist Dexcom made several announcements this year, including receiving FDA clearance for its over-the-counter continuous glucose monitoring (CGM) solution Stelo, G7's expanded capabilities to connect directly to the Apple Watch and, most recently, its $75 million investment in and strategic...
Glucose-monitoring specialist Dexcom announced it has made a $75 million strategic investment in health-tracking ring maker Oura and established a strategic partnership to enable two-way data flow between Dexcom's continuous glucose monitor (CGM) and the Oura Ring.
Dexcom will contribute $75 million to Oura's Series D funding round, which will bring Oura's valuation to more than $5 billion....
The Tandem Diabetes Care t:slim X2 Insulin Pump, which is compatible with glucose monitoring specialist Dexcom's G7 and G6 continuous glucose monitoring (CGM) systems, has been cleared for sale by Health Canada, the department within the government of Canada responsible for national health policy.
t:slim, which holds up to 300 units of insulin, boasts a color touchscreen, a rechargeable battery...
Glucose-monitoring specialist Dexcom announced it is expanding its diabetes-management capabilities by offering direct connectivity to the Apple Watch for its G7 continuous glucose monitoring system via a dedicated Bluetooth connection.
The feature allows users to check their glucose readings in real-time without having their iPhone in hand. It is available in the U.S., U.K. and Ireland, and...
An over-the-counter continuous glucose monitoring (CGM) solution developed by Dexcom called Stelo has received clearance from the Food and Drug Administration (FDA).
Available without the need for a prescription, the wearable biosensor boasts a battery life of up to two weeks and adheres to the back of the upper arm.
The patch aids in the detection of normal (euglycemic) as well as low or high (...
Jolly Good announces new palliative care VR training module
Jolly Good in the United States, in partnership with Harvard-affiliated Brigham and Women’s Hospital, has developed a new VR training module in palliative care communication.
They came up with the VR module to help medical professionals acquire the necessary communication skills to provide care to terminally ill patients and their...
The digital healthcare business of South Korean internet company Kakao Corporation has entered into a collaboration agreement with Dexcom to set up a global digital diabetes management service.
According to a press statement, the deal combines Kakao Healthcare's capabilities in AI and software technology with Dexcom's continuous glucose monitoring (CGM) devices, Dexcom G6 and G7, which the...
Dexcom takes G6 CGM to Singapore
Global CGM device maker Dexcom has launched its latest CGM system in Singapore.
Distributed through its partner DKSH Singapore, the prick-less Dexcom G6 CGM uses a wearable sensor and transmitter to continuously measure and send glucose levels wirelessly to a compatible smart device.
It pairs with a companion mobile app on iOS and Android devices, enabling the...
